Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma

Bibliographic Details
Main Authors:	Uno, Miyuki, Oba-Shinjo, Sueli Mieko, Camargo, Anamaria Aranha, Moura, Ricardo Pereira, de Aguiar, Paulo Henrique, Cabrera, Hector Navarro, Begnami, Marcos, Rosemberg, Sérgio, Teixeira, Manoel Jacobsen, Marie, Suely Kazue Nagahashi
Format:	Online
Language:	English
Published:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180167/

Similar Items

Metabolism and Brain Cancer
by: Marie, Suely Kazue Nagahashi, et al.
Published: (2011)

Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma
by: Marie, Suely Kazue Nagahashi, et al.
Published: (2016)

Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma
by: Gimenez, Marcela, et al.
Published: (2015)

Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels
by: Galatro, Thais Fernanda de Almeida, et al.
Published: (2013)

LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
by: da Silva, Roseli, et al.
Published: (2015)

CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants
by: da Silva, Roseli, et al.
Published: (2013)

Factors associated with serum CA19-9 levels among healthy children: a cross-sectional study
by: Kawai, Sayo, et al.
Published: (2012)

Modulation of HJURP (Holliday Junction-Recognizing Protein) Levels Is Correlated with Glioblastoma Cells Survival
by: Valente, Valeria, et al.
Published: (2013)

Activation of Neural and Pluripotent Stem Cell Signatures Correlates with Increased Malignancy in Human Glioma
by: Holmberg, Johan, et al.
Published: (2011)

CoGA: An R Package to Identify Differentially Co-Expressed Gene Sets by Analyzing the Graph Spectra
by: Santos, Suzana de Siqueira, et al.
Published: (2015)

Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
by: Iliadis, Georgios, et al.
Published: (2012)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas, Reena P, et al.
Published: (2012)

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?
by: Hau, Peter, et al.
Published: (2007)

Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines
by: Ramão, Anelisa, et al.
Published: (2012)

Skeletal muscle major histocompatibility complex class I and II expression differences in adult and juvenile dermatomyositis
by: Shinjo, Samuel Katsuyuki, et al.
Published: (2012)

Personalized treatment strategies in glioblastoma: MGMT promoter methylation status
by: Thon, Niklas, et al.
Published: (2013)

MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas
by: Korfiatis, Panagiotis, et al.
Published: (2016)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
by: Kristensen, Lasse S., et al.
Published: (2016)

IDH mutation and MGMT promoter methylation in glioblastoma: results of a prospective registry
by: Yang, Pei, et al.
Published: (2015)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
by: Melguizo, Consolación, et al.
Published: (2012)

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back?
by: Combs, Stephanie E, et al.
Published: (2011)

Prognostic Value of Three Different Methods of MGMT Promoter Methylation Analysis in a Prospective Trial on Newly Diagnosed Glioblastoma
by: Christians, Arne, et al.
Published: (2012)

MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
by: Skiriute, Daina, et al.
Published: (2012)

Frequent MGMT (06-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
by: Baur, Martina, et al.
Published: (2010)

BMP2 sensitizes glioblastoma stem-like cells to Temozolomide by affecting HIF-1α stability and MGMT expression
by: Persano, L, et al.
Published: (2012)

mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells
by: Smalley, Sarah, et al.
Published: (2014)

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients
by: Quillien, Véronique, et al.
Published: (2014)

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis
by: Yin, An-an, et al.
Published: (2014)

Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme
by: Oberstadt, Moritz C, et al.
Published: (2013)

Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?
by: Berghoff, Anna S., et al.
Published: (2012)

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
by: Smrdel Uros, et al.
Published: (2016-12-01)

Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method
by: Rundle-Thiele, Dayle, et al.
Published: (2015)

The Prognostic Value of Pyrosequencing-Detected MGMT Promoter Hypermethylation in Newly Diagnosed Patients with Glioblastoma
by: Villani, Veronica, et al.
Published: (2015)

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
by: Bienkowski, Michal, et al.
Published: (2015)

Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
by: Adeberg, Sebastian, et al.
Published: (2015)

The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients’ survival: a meta-analysis
by: Zhao, Hailong, et al.
Published: (2016)

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
by: Arita, Hideyuki, et al.
Published: (2016)

Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression
by: Gao, Yong-tao, et al.
Published: (2016)

Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
by: Smrdel, Uros, et al.
Published: (2016)

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression
by: Perazzoli, Gloria, et al.
Published: (2015)